This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Kidney Transplant
and you are
between 18 and 60
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

A prospective, open label study of CERtican in KIdney transplantation

Provided treatments

  • Drug: Everolimus

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01594268. The sponsor of the trial is Novartis Pharmaceuticals and it is looking for 54 volunteers for the current phase.
Official trial title:
A Prospective, Open-label Study to Assess Safety of Certican in Kidney Transplant Patients